| |
|
|
|
|
|
|
 |
|
| A) |
| Application Processing by RCGM |
|
|
|
|
|
| B) |
| Examination of data by the DCG(I) Advisory Committee (Scientific Biosafety and Ethical Issues) |
| Clearance for Phase I clinical trial by DCG(I) |
|
|
|
|
|
| C) |
| Examination of phase I clinical trial data by DCG(I) |
| Clearance for Phase II trials by DCG(I) |
|
|
|
|
|
| D) |
| Examination of Phase II clinical trial data by DCG(I) |
| Clearance for the Phase III clinical trials by DCG(I) |
|
|
|
|
|
| E) |
| Examination of Phase III clinical trial data by DCG(I) in consultation with GEAC |
| Clearance for manufacturing activity by DCG(I) |
|
|
|
|
|
| F) |
| GEAC/DCG(I)/State Drugs Controller |
| Clearance for manufacturing activity |
|
|
